Healthcare
American Oncology Network, Inc.(AONC)
Live Price
Offline$12.00
+20.00% today
1Y Change
-8.40%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $260.00M
- Revenue Growth
- +37.5%
- EPS Growth
- +49.3%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
American Oncology Network, Inc. (AONC) is a Healthcare stock with a market cap of $260.00M and listed on OTC. The stock last traded around $12.00 and down 8.4% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +37.5%, EPS growth of +49.3%, a dividend yield of 0.0%. What stands out right now is revenue +37.5%, EPS +49.3%, free cash flow +14.8% with operating margin -1.0% and ROIC -6.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines AONC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+37.5% vs +7.6% peer median
Operating Margin
Below sector median
-1.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 23, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +37.5% and EPS at +49.3%, with operating margin around -1.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 2 reported quarters, the stock averaged +4.8% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 23, 2026 | โ | +0.0% | +4.3% | -32.6% |
2023 Sep 30, 2023 | โ | +0.3% | +5.3% | -16.1% |
Benchmark Edge
AONC vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
AONC
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
AONC Max Drawdown
-99.29%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for AONC and SPY.
Company Overview
American Oncology Network, Inc.
Other OTC
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
- Leadership
- Todd Schonherz
- IPO Date
- May 5, 2021
- Employees
- 1.9k
- Street Address
- 14543 Global Parkway
- Mailing
- Fort Myers, FL, 33913
- Region
- Fort Myers, FL, US
- Reporting Currency
- USD
- Investor Line
- 833-886-1725
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 191.6
- Price/Sales
- 0.1
- Price/Book
- 6.6
Growth
- Revenue
- +37.5%
- EPS
- +49.3%
- Free Cash Flow
- +14.8%
Profitability
- Gross Margin
- 6.7%
- Operating Margin
- -1.0%
- Net Margin
- -0.2%
- ROE
- 5.6%
- ROIC
- -6.6%
Balance Sheet
- Debt/Equity
- 7.85
- Current Ratio
- 1.53
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.